The study, which was conducted by the University of Southern California, found that two compounds in cannabis – CBGa and CBDa – were effective in preventing COVID-19 infection.
The study’s lead author, Dr. David Agus, said that these compounds work by binding to receptors in the body that are responsible for viral entry. In other words, they prevent the virus from being able to enter cells and cause infection.
What is CBGa and CBDa
CBDa and CBGa are both cannabinoid acids, of which dozens are found within cannabis (both hemp and marijuana plants),
including tetrahydrocannabinol acid (THCa), cannabichromenenic acid (CBCa). CBGa stands for cannabigerolic acid, and CBDa stands for cannabidiol acid.
However, CBDa is the more common name since it’s a direct precursor to CBD. So, what’s the difference between these two cannabinoid acids?
The main difference between CBDa vs. CBD is in their chemical makeup. Both contain a carboxyl group (-COOH), which is responsible for their acidic properties. However, CBD has an extra hydroxyl group (-OH) attached to its structure.
This makes CBDa a more potent antioxidant and antibacterial than CBD. Additionally, CBDa is thought to be more effective in treating depression, nausea, and side effects associated with cancer treatment.
So, if you’re looking for a cannabinoid acid with potential therapeutic benefits,
CBDa may be a better option than CBD. However, more research is needed to confirm these claims.
The COVID-19 & Cannabinoids Study
The study’s aim was to test the efficacy of more than 100 cannabinoids against SARS-CoV-2. The team found that some cannabinoids were able to completely block viral entry into human cells,
while others only partially blocked it. Overall, the cannabinoids tested in this study showed promise as potential treatments for COVID-19 and its variants.
The most effective cannabinoids against SARS-CoV-2 were CBGa and CBDa, which are found in cannabis. CBGa and CBDa have high affinities for the spike glycoprotein of the SARS-CoV-2 virus,
which is what the virus uses to attach and enter a healthy cell. CBGa and CBDa were found to be effective against both the alpha and beta variants of COVID-19, suggesting that they may be useful against future variants as well.
The study’s findings suggest that cannabinoids could be used as a treatment for COVID-19, either alone or in combination with other drugs.
Further research is needed to determine the most effective dose and delivery method for cannabinoids. However, the study’s authors believe that cannabinoids could be a safe and effective treatment for COVID-19 and its variants.
COVID-19 Prevention Myths
There are currently no known cures or preventive measures for COVID-19. The most effective way to protect yourself from the virus is to practice good hygiene and social distancing, and to get vaccinated when the vaccine becomes available.
There have been many false claims of potential cures for COVID-19, but these have all been debunked by the scientific community.
Some of the more popular false claims include: taking hot baths or using saline rinses to kill the virus, using supplements like vitamins C and D (which are helpful for boosting your immune system,
but not found to protect against the coronavirus), and drinking bleach or other disinfectants. If you come across any of these claims, be sure to do your research before believing them.
The best way to get accurate information about COVID-19 is from trusted sources like the Centers for Disease Control and Prevention (CDC) or the World Health Organization (WHO).
More Research on Cannabinoids and COVID-19
CBD has been shown to help prevent and treat COVID-19 in several studies. One study, published in Science Advances in January 2022, found that patients given CBD had lower infection rates.
Their observation was that CBD up-regulates stress responses and interferon signaling pathways, resulting in the body more aggressively attacking the incoming SARS-CoV-2 virus.
Other studies have found that CBD can help reduce the severity of symptoms and improve recovery time in patients with COVID-19.
A study published in September 2020 in the Journal of Molecular Biology found that CBD was able to decrease the levels of pro-inflammatory cytokines in patients with COVID-19, helping to reduce the symptoms of the disease.
Still, more research is needed on CBD and its potential role in treating COVID-19. While the findings are promising, cannabis should not be used as a treatment for COVID-19 unless it is prescribed by a healthcare professional.